Table III.
Variable | Hazard ratio | 95% CI | P-value |
---|---|---|---|
NLR | >0.05 | ||
Normal (<3.0) | Ref | ||
High (≥3.0) | 2.93 | 1.29–6.64 | |
BMI | 0.09 | ||
Underweight (<18.5) | Ref | ||
Normal range (18.5≤ BMI <25) | 0.38 | 0.09–1.44 | |
Overweight/obese (BMI ≥25) | 0.88 | 0.21–3.72 | |
Menopause | 0.28 | ||
Premenopausal | Ref | ||
Postmenopausal | 1.56 | 0.69–3.47 | |
LDH | 1.00 | 1.00–1.00 | >0.05 |
Subtypes | >0.05 | ||
ER+, HER− | Ref | ||
ER+, HER+ | 0.28 | 0.05–1.43 | |
Triple negative type | 3.31 | 1.01–10.86 | |
HER2 type | 0.77 | 0.29–2.08 |
Ref, reference; NLR, neutrophil-to-lymphocyte ratio; BMI, body mass index; LDH, lactate dehydrogenase; ER, estrogen receptor; HER; human epidermal growth factor 2 receptor; CI, confidence interval.